Abstract:Helicobacter pylori (H. pylori) infection, which affects approximately half of the world's population, remains a serious public health problem. As H. pylori infection leads to a number of gastric pathologies, including inflammation, gastroduodenal ulcers, and malignancies, early detection and treatment are crucial to preventing the spread of the infection. Multiple extragastric complications, such as iron deficiency anaemia, immune thrombocytopenic purpura, vitamin B12 deficiency, diabetes mellitus, cardiovascular diseases, and certain neurological disorders, have also been linked to H. pylori infection. An awareness of H. pylori and associated health hazards is necessary to minimize or even eradicate the infection. Therefore, there is an urgent need to raise the standards for the currently employed diagnostic, eradication, alternative treatment strategies. In addition, a brief overview of traditional and cutting-edge approaches that have proven effective in identifying and managing H. pylori is needed. Based on the test and laboratory equipment available and patient clinical characteristics, the optimal diagnostic approach requires weighing several factors. The pathophysiology and pathogenic mechanisms of H. pylori should also be studied, focusing more on the infection-causing virulence factors of this bacterium. Accordingly, this review aims to demonstrate the various diagnostic, pathophysiological, therapeutic, and eradication tactics available for H. pylori, emphasizing both their advantages and disadvantages. Invasive methods (such as quick urease testing, biopsy, or culture) or noninvasive methods (such as breath tests, stool investigations, or serological tests) can be used. We also present the most recent worldwide recommendations along with scientific evidence for treating H. pylori. In addition to the current antibiotic regimens, alternative therapies may also be considered. It is imperative to eradicate the infections caused by H. pylori as soon as possible to prevent problems and the development of stomach cancer. In conclusion, significant advances have been made in identifying and treating H. pylori. To improve eradication rates, peptide mass fingerprinting can be used as a diagnostic tool, and vaccines can also eliminate the infection.

Pathogenesis and clinical management of Helicobacter pylori gastric infection

Helicobacter pylori infection: Beyond gastric manifestations

Helicobacter pylori: A Contemporary Perspective on Pathogenesis, Diagnosis and Treatment Strategies

Pathophysiology and clinical relevance of Helicobacter pylori

Helicobacter Pylori Infection: A Recent Approach to Diagnosis and Management

Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms

Diagnostic Methods for Helicobacter pylori

Helicobacter pylori Infection: New Facts in Clinical Management

Helicobacter pylori Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges

Helicobacter: Inflammation, immunology and vaccines

Updates to the Diagnosis and Clinical Management of Helicobacter pylori Infections

Helicobacter pylori infection: a dynamic process from diagnosis to treatment

Advances on diagnosis of Helicobacter pylori infections

Overview of Helicobacter pylori Infection: Clinical Features, Treatment, and Nutritional Aspects

Impact of Helicobacter pylori Virulence Factors on the Host Immune Response and Gastric Pathology

Review article: natural history and epidemiology of Helicobacter pylori infection

Helicobacter pylori in oral cavity: current knowledge

Helicobacter pylori. One bacterium and a broad spectrum of human disease! An overview

The Role of Helicobacter pylori in Pathogenesis: the Spectrum of Clinical Outcomes

Prevalence of cagA, cagM, vacA and oipA genes in isolates of Helicobacter pylori obtained from hospital patients in Northeast Brazil

Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings